Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine J McMahan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
T cell receptor revision does not solely target recent thymic emigrantsCristine J Cooper, Mark T Orr, Catherine J McMahan, et al.
International Journal of Clinical and Experimental Pathology|April 14, 2011
Prostatic acid phosphatase expression in human tissuesThomas J Graddis, Catherine J McMahan, Jennifer Tamman, et al.
Immunobiology|December 1, 2004
Tumor immunotherapy with alternative reading frame peptide antigensThomas J Graddis, Michael L Diegel, Catherine J McMahan, et al.
Cellular Immunology|December 6, 2011
Modulation of TCRβ surface expression during TCR revisionKalynn B Simmons, Maramawit Wubeshet, Kristina T Ames, et al.
Molecular Cancer Therapeutics|July 14, 2016
MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate CancerGabriela Hernandez-Hoyos, Toddy Sewell, Robert Bader, et al.
Frontiers in Immunology|November 19, 2024
Preclinical characterization of MTX-101: a novel bispecific CD8 Treg modulator that restores CD8 Treg functions to suppress pathogenic T cells in autoimmune diseasesJennifer L Gardell, Meghan E Maurer, Monica M Childs, et al.
Molecular Cancer Therapeutics|November 7, 2022
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical StudiesMichelle H Nelson, Sara Fritzell, Robert Miller, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
T cell receptor revision does not solely target recent thymic emigrantsCristine J Cooper, Mark T Orr, Catherine J McMahan, et al.
International Journal of Clinical and Experimental Pathology|April 14, 2011
Prostatic acid phosphatase expression in human tissuesThomas J Graddis, Catherine J McMahan, Jennifer Tamman, et al.
Immunobiology|December 1, 2004
Tumor immunotherapy with alternative reading frame peptide antigensThomas J Graddis, Michael L Diegel, Catherine J McMahan, et al.
Cellular Immunology|December 6, 2011
Modulation of TCRβ surface expression during TCR revisionKalynn B Simmons, Maramawit Wubeshet, Kristina T Ames, et al.
Molecular Cancer Therapeutics|July 14, 2016
MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate CancerGabriela Hernandez-Hoyos, Toddy Sewell, Robert Bader, et al.
Frontiers in Immunology|November 19, 2024
Preclinical characterization of MTX-101: a novel bispecific CD8 Treg modulator that restores CD8 Treg functions to suppress pathogenic T cells in autoimmune diseasesJennifer L Gardell, Meghan E Maurer, Monica M Childs, et al.
Molecular Cancer Therapeutics|November 7, 2022
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical StudiesMichelle H Nelson, Sara Fritzell, Robert Miller, et al.
Pageof 1